Ownership history in ALGERT GLOBAL LLC · 8 quarters on record
This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in FULCRUM THERAPEUTICS INC (FULC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 16,550 | -19,597 | -54.2% | 0.00% | $152K | $9.20 |
| 2025 Q1 | ADDED | 36,147 | +2,030 | +6.0% | 0.00% | $104K | $2.88 |
| 2024 Q4 | REDUCED | 34,117 | -5,570 | -14.0% | 0.00% | $160K | $4.70 |
| 2024 Q3 | REDUCED | 39,687 | -1,616 | -3.9% | 0.00% | $142K | $3.57 |
| 2024 Q2 | ADDED | 41,303 | +27,633 | +202.1% | 0.01% | $256K | $6.20 |
| 2024 Q1 | REDUCED | 13,670 | -12,160 | -47.1% | 0.01% | $129K | $9.44 |
| 2023 Q4 | REDUCED | 25,830 | -5,180 | -16.7% | 0.01% | $174K | $6.75 |
| 2023 Q3 | INITIATED | 31,010 | — | — | 0.01% | $138K | — |
As of 2025 Q4 — sorted by position size